Acasti Pharma (ACST) Earnings Date, Estimates & Call Transcripts → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free ACST Stock Alerts $2.94 +0.06 (+2.08%) (As of 04/24/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateJun. 28EstimatedActual EPS (Feb. 12) -$0.21 Beat By $0.02 Consensus EPS (Feb. 12) -$0.23 Get Acasti Pharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for ACST and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueACST Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ACST Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Acasti Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.63)($0.63)($0.63)Q2 20241($0.29)($0.29)($0.29)Q3 20241($0.30)($0.30)($0.30)Q4 20241($0.35)($0.35)($0.35)FY 20244($1.57)($1.57)($1.57)ACST Earnings Date and InformationAcasti Pharma last announced its earnings data on February 12th, 2024. The biopharmaceutical company reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.02. Acasti Pharma has generated ($5.08) earnings per share over the last year (($5.08) diluted earnings per share). Earnings for Acasti Pharma are expected to grow in the coming year, from ($1.44) to ($1.29) per share. Acasti Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 28th, 2024 based off prior year's report dates.Read More Acasti Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 6/28/2024Estimated)------- 2/12/2024Q4 2023($0.23)($0.21)+$0.02($0.21)--11/13/2023Q2 2024($0.29)($0.19)+$0.10$0.05--8/11/2023Q1 2024($0.63)($0.34)+$0.29($0.14)--6/23/2023Q4 2023($0.78)($0.30)+$0.48$3.30--2/14/2023Q3 2023($0.78)($0.54)+$0.24($0.09)--11/14/2022Q2 2023-($0.66)($0.66)($0.11)-- Get the Latest News and Ratings for ACST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Q1 2023-($0.60)($0.60)($0.10)--6/21/2022Q4 2022($0.78)($0.24)+$0.54($0.04)--2/14/2022Q3 2022($0.48)($0.54)($0.06)($0.09)--11/10/2021Q2 2022-$0.18+$0.18$0.03--8/12/2021Q1 2022-($0.48)($0.48)($0.08)--6/22/2021Q4 2021-($1.44)($1.44)($0.03)-- Acasti Pharma Earnings - Frequently Asked Questions When is Acasti Pharma's earnings date? Acasti Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 28th, 2024 based off last year's report dates. Learn more on ACST's earnings history. Did Acasti Pharma beat their earnings estimates last quarter? In the previous quarter, Acasti Pharma (NASDAQ:ACST) reported ($0.21) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.02. Learn more on analysts' earnings estimate vs. ACST's actual earnings. How much profit does Acasti Pharma generate each year? Acasti Pharma (NASDAQ:ACST) has a recorded net income of -$42.43 million. ACST has generated -$5.08 earnings per share over the last four quarters. What is Acasti Pharma's EPS forecast for next year? Acasti Pharma's earnings are expected to grow from ($1.44) per share to ($1.29) per share in the next year. More Earnings Resources from MarketBeat Related Companies: LIAN Earnings FRLN Earnings BCLI Earnings LPCN Earnings TCRT Earnings SABS Earnings KALA Earnings ZIVO Earnings BLRX Earnings AVRO Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:ACST) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acasti Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
